Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.7 USD -1.23% Market Closed
Market Cap: 973.4m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Zymeworks Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zymeworks Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NASDAQ:ZYME
Long-Term Debt
$33k
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$58B
CAGR 3-Years
-8%
CAGR 5-Years
13%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
$21.5B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$57.1B
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$346.6m
CAGR 3-Years
-13%
CAGR 5-Years
-9%
CAGR 10-Years
-4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
18%

See Also

What is Zymeworks Inc's Long-Term Debt?
Long-Term Debt
33k USD

Based on the financial report for Jun 30, 2024, Zymeworks Inc's Long-Term Debt amounts to 33k USD.

What is Zymeworks Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-31%

Over the last year, the Long-Term Debt growth was -67%. The average annual Long-Term Debt growth rates for Zymeworks Inc have been -31% over the past three years .

Back to Top